Transcriptional induction of DLC-1 gene through Sp1 sites by histone deacetylase inhibitors in gastric cancer cells

다국어 초록 (Multilingual Abstract)

We previously reported that trichostatin A (TSA), a histone deacetylase (HDAC) inhibitor, induced DLC-1 mRNA expression and accumulated acetylated histones H3 and H4 associated with the DLC-1 promoter in DLC-1 non-expressing gastric cancer cells. In this study, we demonstrated the molecular mechanisms by which TSA induced the DLC-1 gene expression.
Treatment of the gastric cancer cells with TSA activates the DLC-1 promoter activity through Sp1 sites located at -219 and -174 relative to the transcription start site.
Electrophoretic mobility-shift assay (EMSA) revealed that Sp1 and Sp3 specifically interact with these Sp1 sites and showed that TSA did not change their binding activities. The ectopic expression of Sp1, but not Sp3, enhances the DLC-1 promoter responsiveness by TSA. Furthermore, the TSA-induced DLC-1 promoter activity was increased by p300 expression and reduced by knockdown of p300. These results demonstrated the requirement of specific Sp1 sites and dependence of Sp1 and p300 for TSA-mediated activation of DLC-1 promoter.

참고문헌 (Reference)

1 Xiao H, "p300 collaborates with Sp1 and Sp3 in p21 (waf1/cip1) promoter activation induced by histone deacetylase inhibitor" 275 : 1371-6, 2000

2 Ying J, "Tumor-specific methylation of the 8p22 tumor suppressor gene DLC1 is an epigenetic biomarker for Hodgkin, nasal NK/T-cell and other types of lymphomas" 2 : 15-21, 2007

3 TacGhee Yi, "Trichostatin A-mediated upregulation of p21 WAF1 contributes to osteoclast apoptosis" 대한생화학ㆍ분자생물학회 39 (39): 213-221, 2007

4 Kim TY, "Transcriptional silencing of the DLC-1 tumor suppressor gene by epigenetic mechanism in gastric cancer cells" 22 : 3943-51, 2003

5 Seng TJ, "The major 8p22 tumor suppressor DLC1 is frequently silenced by methylation in both endemic and sporadic nasopharyngeal, esophageal, and cervical carcinomas, and inhibits tumor cell colony formation" 26 : 934-44, 2007

6 Liu G, "The activation domains, the proline-rich domain, and the C-terminal basic domain in p53 are necessary for acetylation of histones on the proximal p21 promoter and interaction with p300/CREB-binding protein" 278 : 17557-65, 2003

7 Goodison S, "The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells" 65 : 6042-53, 2005

8 Hagen G, "Sp1-mediated transcriptional activation is repressed by Sp3" 13 : 3843-51, 1994

9 Mackay DJ, "Rho GTPases" 273 : 20685-8, 1998

10 Kwon HS, "Retinoic acids and trichostatin A (TSA), a histone deacetylase inhibitor, induce human pyruvate dehydrogenase kinase 4 (PDK4) gene expression" 1759 : 141-51, 2006

11 Zhao S, "Requirement of a specific Sp1 site for histone deacetylasemediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells" 63 : 2624-30, 2003

12 Yuan BZ, "Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers" 140 : 113-7, 2003

13 Owen GI, "Progesterone regulates transcription of the p21 (WAF1) cyclindependent kinase inhibitor gene through Sp1 and CBP/p300" 273 : 10696-701, 1998

14 Hiramoto M, "Nuclear targeted suppression of NF-kappa B activity by the novel quinone derivative E3330" 160 : 810-9, 1998

15 Chen ZY, "Krüppel-like factor 4 is transactivated by butyrate in colon cancer cells" 134 : 792-8, 2004

16 Jin Y, "Inhibition of DLC-1 gene expression by RNA interference in the colon cancer LoVo cell line" 19 : 669-74, 2008

17 de Ruijter AJ, "Histone deacetylases (HDACs): characterization of the classical HDAC family" 370 : 737-49, 2003

18 Yokota T, "Histone deacetylase inhibitors activate INK4d gene through Sp1 site in its promoter" 23 : 5340-9, 2004

19 Sowa Y, "Histone deacetylase inhibitor activates the WAF1/Cip1 gene promoter through the Sp1 sites" 241 : 142-50, 1997

20 Eberharter A, "Histone acetylation: a switch between repressive and permissive chromatin. Second in review series on chromatin dynamics" 3 : 224-9, 2002

21 Song YF, "High-frequency promoter hypermethylation of the deleted in liver cancer-1 gene in multiple myeloma" 59 : 947-51, 2006

22 Pang JC, "Epigenetic inactivation of DLC-1 in supratentorial primitive neuroectodermal tumor" 36 : 36-43, 2005

23 Shi H, "Discovery of novel epigenetic markers in non-Hodgkin's lymphoma" 28 : 60-70, 2007

24 Xue W, "DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma" 22 : 1439-44, 2008

25 Durkin ME, "DLC-1:a Rho GTPaseactivating protein and tumour suppressor" 11 : 1185-207, 2007

26 Kim TY, "DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma" 355 : 72-7, 2007

27 Healy KD, "DLC-1 suppresses non-small cell lung cancer growth and invasion by RhoGAP-dependent and independent mechanisms" 47 : 326-37, 2008

28 Yuan BZ, "DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas" 23 : 1405-11, 2004

29 Ng IO, "DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1" 60 : 6581-4, 2000

30 Yuan BZ, "DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity" 22 : 445-50, 2003

31 Yuan BZ, "Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP" 58 : 2196-9, 1998

32 Guan M, "Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications" 12 : 1412-9, 2006